Journey Medical Corp
NASDAQ:DERM
Journey Medical Corp
NASDAQ:DERM
Price:
5.61 USD
19.36%
Market Closed
Updated:
Jun 11, 2024
Journey Medical Corp
Interest Income Expense
|
Journey Medical Corp
Interest Income Expense Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Journey Medical Corp
NASDAQ:DERM
|
Interest Income Expense
-$1.6m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$212m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$676m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$1.5B
|
CAGR 3-Years
130%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-13%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$368m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-30%
|
See Also
What is Journey Medical Corp's Interest Income Expense?
Interest Income Expense
-1.6m
USD
-1.6m
USD
Based on the financial report for Dec 31, 2023, Journey Medical Corp's Interest Income Expense amounts to -1.6m USD.
What is Journey Medical Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-31%
-31%
Over the last year, the Interest Income Expense growth was 24%. The average annual Interest Income Expense growth rates for Journey Medical Corp have been -31% over the past three years .
You don't have any saved screeners yet
